Please select the option that best describes you:
Topics:
Gynecologic Oncology • Medical Oncology
For a borderline ovarian tumor that has been resected with BSO and hysterectomy, would you consider endocrine therapy if found to be ER-positive?
What patient or disease factors would push you towards utilization of this therapy (e.g., stage, tumor spillage, histologic subtype)?